Biotech Startups

Avere Therapeutics is a biotech company developing AVR-001, an oral once-weekly interleukin-23 receptor antagonist (IL-23RA) for chronic inflammatory diseases such as psoriasis, ulcerative colitis, Crohn's disease, and psoriatic arthritis. The drug is engineered for higher, more consistent drug exposure and a longer half-life to enable once-weekly pill dosing.

1 investor

Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.

1 investor

Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.

1 investor

Aviana Molecular Technologies develops diagnostic products focused on identifying infectious diseases to address unmet clinical needs. Founded in 2008, the company operates at the intersection of healthcare diagnostics and infection detection.

1 investor

Avid Bio provides development and manufacturing services for biologics programs, offering integrated support from early-stage development through commercialization. The company partners with pharmaceutical and biotech teams as a contract development and manufacturing organization (CDMO) with US-based operations.

1 investor

Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases. Through its Avirmax CMC (ACI) division, it also provides bioprocess development and manufacturing services for AAV-based gene therapies to external customers.

1 investor

Avisa Myko manufactures water-soluble, affordable natural eumelanin using a patented process, supplying the pigment for applications in cosmetics, radiation shielding, biomedicine, batteries, fuel cells, and organic semiconductors/biosensors. It works through partnerships to develop melanin-based products for human health and environmental uses.

1 investor

Avista develops gene therapy technology, using AI platforms that draw on capsid biology, structural dynamics, and protein design to improve capsid design, manufacturing, and gene delivery. The company works in the genetic medicine field, aiming to advance gene therapy development and patient access.

1 investor

Avivo develops enzyme-based technology to convert blood types and enable organ compatibility, increasing access to transfusions and transplants while reducing waste in healthcare systems. The company serves hospitals, transplant centers, military and emergency care settings with a platform designed to integrate into existing clinical workflows.

1 investor

Avotres is a biopharmaceutical company developing therapeutics targeting autoimmune diseases and cancer. Its work centers on a pipeline of drug candidates addressing immune-related conditions.

1 investor

Selvedge Venture is a venture capital firm that invests in Pre-Seed, Seed and Series A startups working to address age-related medical conditions, focusing on metabolic syndrome, cancer and neurodegenerative diseases. It backs companies operating at the intersection of biotechnology and digital technologies such as machine learning and integrated data.

1 investor

AVROBIO develops ex vivo lentiviral vector-based hematopoietic stem cell gene therapies to treat lysosomal disorders by permanently integrating therapeutic genes into patient stem cells manufactured outside the body. The modified cells differentiate into multiple cell types capable of crossing the blood-brain barrier to deliver treatment throughout the body and central nervous system.

1 investor

AVS Bio raises Specific Pathogen Free (SPF) chickens in US-based biosecurity facilities for use in vaccine manufacturing, quality control testing, and research applications. The company supplies pathogen-free birds of various ages to pharmaceutical, biotech, and research organizations requiring controlled biological systems for regulatory and scientific work.

1 investor

Avvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa. It is the regional arm of Avvio Medical, whose investigational medical device has not yet received regulatory clearance.

1 investor

Acoustic Wave Cell Therapy (AWCT) develops a medical technology platform for treating conditions such as erectile dysfunction and urinary incontinence, based on research licensed from UCSF. The company holds exclusive rights to the technology, which remains an investigational device.

1 investor

Awen Oncology is a drug discovery company developing first-in-class oncology therapeutics that target cancer-specific proteins found only in tumor cells, aiming for treatments with improved efficacy and fewer side effects. It combines high-throughput cell and molecular biology with computational techniques to identify novel therapeutic targets for cancer patients.

1 investor

A life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.

1 investor

Axcelead is a healthcare platform company with drug discovery as its core business, supporting pharmaceutical research for biotech ventures, pharmaceutical companies, and academic institutions. The company provides comprehensive drug discovery solutions leveraging advanced screening systems, compound libraries, and experienced researchers.

1 investor

AxCell Labs is a Canadian medical device company developing regenerative implants for soft tissue reconstruction, based on an implantable biomaterial derived from bacterial cellulose. Its lead product is a regenerative dermal injectable that restores volume and guides the formation of living, vascularized tissue, with a further soft-tissue implant for ENT applications in development.

1 investor

Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection. Its analytical chemistry systems serve pharmaceutical, chemical, and educational customers for lab and production-line analysis.

1 investor

Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.

1 investor

Axent Biosciences develops stem cell therapies to treat diseases like Parkinson's, using a proprietary cell cultivation platform to enable scalable and cost-effective manufacturing. The company was spun out of UC Berkeley research and aims to make stem cell therapies broadly accessible.

1 investor

Axial Orthopaedics is a medtech company in orthopedic healthcare, with leadership experienced in strategic exits.

1 investor

Axia is a vegetable seed breeding company that develops high-quality tomato and vegetable varieties for greenhouse cultivation, both heated and unheated, with or without artificial light. The company focuses on taste, quality, and yield through state-of-the-art research and development, serving growers and supply chain partners globally.

1 investor